GenePharma is fast becoming an established name in the field of miRNA detection and modulation, and the broader field of RNAi, with over 4500 customer published papers in the literature.

The company has cutting edge core technologies for siRNA chemical synthesis, in particular for miRNA regulation and detection, including RNA monomer synthesis technology, chemically-modified siRNA oligo synthesis technology, nucleic acid fluorescent labeling technology.

GenePharma has adopted stringent standardized management practices in product development, production, packaging, storage, as well as its financial management, sales management and logistics management and has acheived ISO9000 quality management standards.